TD Securities Boosts Vitalhub (TSE:VHI) Price Target to C$14.00

Vitalhub (TSE:VHI) had its price target lifted by TD Securities from C$13.00 to C$14.00 in a research report issued on Monday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock. TD Securities’ target price indicates a potential upside of 39.17% from the company’s current price.

Several other analysts have also recently weighed in on VHI. Scotiabank set a C$14.00 price target on shares of Vitalhub and gave the company an “outperform” rating in a research note on Thursday, January 30th. Raymond James set a C$13.50 price objective on shares of Vitalhub and gave the company an “outperform” rating in a report on Thursday. Finally, Canaccord Genuity Group lifted their price target on shares of Vitalhub from C$12.00 to C$12.50 and gave the company a “buy” rating in a research report on Thursday, January 16th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Vitalhub currently has an average rating of “Buy” and an average price target of C$12.08.

Vitalhub Trading Down 1.8 %

VHI traded down C$0.18 during midday trading on Monday, hitting C$10.06. 100,509 shares of the company traded hands, compared to its average volume of 145,951. Vitalhub has a 52-week low of C$5.80 and a 52-week high of C$12.09. The business has a 50 day simple moving average of C$10.48 and a two-hundred day simple moving average of C$10.35. The company has a market capitalization of C$544.17 million, a price-to-earnings ratio of 163.62, a PEG ratio of 1.18 and a beta of 1.26.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.